Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents. 2014

Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
Dipartimento di Scienze Farmaceutiche, Via Fossato di Mortara 17-19, Università di Ferrara, 44121 Ferrara, Italy. Electronic address: rmr@unife.it.

In search of new compounds with strong antiproliferative activity and simple molecular structure, we designed a novel series of agents based on the 2-amino-3-alkoxycarbonyl/cyano-5-arylethylthiophene scaffold. The presence of the ethyl spacer between the 2',5'-dimethoxyphenyl and the 5-position of the thiophene ring, as well as the number and location of methoxy substitutents on the phenyl ring, played a profound role in affecting the antiproliferative activity. Among the synthesized compounds, we identified the 2-amino-3-cyano-[2-(2,5-dimethoxyphenyl)ethyl] thiophene 2c as the most promising derivative against a wide panel of cancer cell lines (IC50=17-130 nM). The antiproliferative activity of this compound appears to correlate well with its ability to inhibit tubulin assembly and the binding of colchicine to tubulin. Moreover 2c, as determined by flow cytometry, strongly induced arrest in the G2/M phase of the cell cycle, and annexin-V and propidium iodide staining indicate that cell death proceeds through an apoptotic mechanism that follows the intrinsic mitochondrial pathway.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene

Related Publications

Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
December 2013, ACS medicinal chemistry letters,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
April 2000, Bioorganic & medicinal chemistry letters,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
May 2024, Bioorganic chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
January 2019, Frontiers in chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
September 2018, Molecules (Basel, Switzerland),
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
November 2020, Bioorganic chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
May 2019, Archiv der Pharmazie,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
March 2014, Chemical biology & drug design,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
December 2019, BMC chemistry,
Romeo Romagnoli, and Pier Giovanni Baraldi, and Carlota Lopez-Cara, and Maria Kimatrai Salvador, and Delia Preti, and Mojgan Aghazadeh Tabrizi, and Jan Balzarini, and Peter Nussbaumer, and Marcella Bassetto, and Andrea Brancale, and Xian-Hua Fu, and Yang-Gao, and Jun Li, and Su-Zhan Zhang, and Ernest Hamel, and Roberta Bortolozzi, and Giuseppe Basso, and Giampietro Viola
October 2013, Chemical biology & drug design,
Copied contents to your clipboard!